Macrogen Expands Its Operation in the United States

Published: 2004-12-22 06:55:00

Updated: 2004-12-22 06:55:00

Macrogen Inc., a domestic biotechnology venture company, has launched its overseas business operation in the United States, by establishing Macrogen Corporation in Rockville, Maryland, effective January 1, 2005.

An official from Macrogen stated, “the establishment of a U.S. based corporation i...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK